Halothane-induced hepatitis: Paradigm or paradox for drug-induced liver injury

Authors

  • Mark J Kurth Ph.D.,

    1. Department of Chemistry, University of California at Davis, Davis, CA
    Search for more papers by this author
  • Tsuyoshi Yokoi Ph.D.,

    1. Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine, Japan
    Search for more papers by this author
  • M. Eric Gershwin M.D.

    Corresponding author
    1. Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA
    • Address reprint requests to: M. Eric Gershwin, M.D., Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 Health Sciences Drive, Suite 6510, Davis, CA 95616. E-mail: megershwin@ucdavis.edu; fax: 530-752-4669.

    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

  • Funding support provided by a grant from the National Institutes of Health (DK067003).

  • See Article on Page 1741

No abstract is available for this article.

Ancillary